UnitedHealth Group Inc (NYSE:UNH) – Investment analysts at Leerink Swann raised their FY2018 earnings estimates for UnitedHealth Group in a note issued to investors on Wednesday. Leerink Swann analyst A. Gupte now forecasts that the healthcare conglomerate will post earnings of $12.60 per share for the year, up from their prior forecast of $10.80. Leerink Swann has a “Outperform” rating on the stock. Leerink Swann also issued estimates for UnitedHealth Group’s FY2019 earnings at $14.40 EPS and FY2020 earnings at $16.50 EPS.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.11 EPS.
UnitedHealth Group (NYSE:UNH) traded up $0.19 on Friday, reaching $243.35. 4,279,283 shares of the company’s stock were exchanged, compared to its average volume of 3,634,767. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The stock has a market cap of $234,890.00, a P/E ratio of 22.72, a price-to-earnings-growth ratio of 1.45 and a beta of 0.66. UnitedHealth Group has a 1 year low of $156.49 and a 1 year high of $243.90.
Hedge funds and other institutional investors have recently modified their holdings of the business. Capital International Investors boosted its stake in shares of UnitedHealth Group by 399.3% during the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares during the period. Jennison Associates LLC boosted its stake in shares of UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares during the period. Janus Henderson Group PLC boosted its stake in shares of UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares during the period. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC boosted its stake in shares of UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares during the period. Institutional investors and hedge funds own 86.09% of the company’s stock.
In related news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,655 shares of company stock worth $7,469,083. 0.89% of the stock is owned by company insiders.
WARNING: This piece of content was originally published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/19/fy2018-eps-estimates-for-unitedhealth-group-inc-increased-by-leerink-swann-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.